kabutan

Delta-Fly Pharma, Inc.(4598) Summary

4598
TSE Growth
Delta-Fly Pharma, Inc.
229
JPY
-4
(-1.72%)
Jan 29, 1:36 pm JST
1.49
USD
Jan 28, 11:36 pm EST
Result
PTS
outside of trading hours
229.3
Jan 29, 1:33 pm JST
Summary Chart Historical News Financial Result
PER
PBR
7.91
Yield
ー%
Margin Trading Ratio
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
231 JPY 1.50 USD
Previous Close Jan 28
233 JPY 1.52 USD
High Jan 29, 9:00 am
231 JPY 1.50 USD
Low Jan 29, 9:01 am
226 JPY 1.47 USD
Volume
355,500
Trading Value
0.08B JPY 0.53M USD
VWAP
228.57 JPY 1.49 USD
Minimum Trading Value
22,900 JPY 149 USD
Market Cap
2.78B JPY 0.02B USD
Number of Trades
230
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Slightly High
1-Year Average
870
1-Year High Dec 10, 2025
15,787
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 0 2,541,500
Jan 16, 2026 0 2,748,700
Jan 9, 2026 1,400 1,811,200 1293.71
Dec 26, 2025 0 1,949,400
Dec 19, 2025 2,700 1,993,500 738.33
Company Profile
Delta-Fly Pharma, Inc. is a bioventure company developing anticancer drugs. The company handles everything from research and development to manufacturing and sales.
Sector
Pharmaceuticals
Delta-Fly Pharma, Inc. is a bioventure company that consistently handles the entire process from research and development to manufacturing and sales of anticancer drugs. Using its proprietary "modular drug discovery" method, the company aims to create new anticancer drugs with an excellent balance of clinical efficacy and safety by combining existing anticancer active substances. With multiple development pipelines, the company is conducting clinical trials targeting recurrent and refractory acute myeloid leukemia, lung cancer, pancreatic cancer, and other conditions. Their business model is based on generating revenue through product sales, milestone payments, and royalty income by out-licensing sales rights to pharmaceutical companies. Focusing on licensing agreements with pharmaceutical companies, Delta-Fly Pharma has established an efficient research and development system by utilizing external resources.